Plasma changes in breast cancer patients during endocrine therapy ? lipid measurements and nuclear magnetic resonance (NMR) spectroscopy

High density lipoprotein as a protective factor against coronary heart disease

Tavia Gordon, William P. Castelli, Marthana C. Hjortland et al. · The American Journal of Medicine · 1977 · 5.1K citations

Medicine, Cardiology, Preventive Medicine +16

Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients With Node-Negative Breast Cancer

R. R. Love, Polly A. Newcomb, Donald A. Wiebe et al. · JNCI Journal of the National Cancer Institute · 1990 · 293 citations

Medicine, Oncology, Pharmacology +16

Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programme

Trevor J. Powles, C R Tillyer, Alison L. Jones et al. · European Journal of Cancer and Clinical Oncology · 1990 · 160 citations

Medicine, Gynecology, Oncology +14

Tamoxifen, serum lipoproteins and cardiovascular risk

PF Bruning, JMG Bonfrer, A.A.M. Hart et al. · British Journal of Cancer · 1988 · 147 citations · Full text

Medicine, Endocrinology, Oncology +14

THE PREVENTION OF BREAST CANCER

Jack Cuzick, D.Y Wang, R.D. Bulbrook · The Lancet · 1986 · 143 citations

Medicine, Oncology, Preventive Medicine +8